Special Issue "Antimicrobial Activity of Plant-Derived Products and Synthetic Derivatives"
Deadline for manuscript submissions: 31 May 2021.
Interests: discovery and development of small organic molecules and of natural product analogues or derivatives with anticancer, antibacterial and antiparasitic activity; synthesis of multitarget inhibitors and of hybrids or bioconjugates aiming at improvement of the pharmacological profile of one or more bioactive molecules
Special Issues and Collections in MDPI journals
Special Issue in Molecules: Discovery, Synthesis and Evaluation of Bioactive Compounds
Interests: biopesticides; antioxidants; enzymes inhibition; neurotoxins; ecotoxicology; secondary metabolites; antifungal; antibacterial; nutraceuticals; natural anticancer
Interests: plant-derived products; antibacterial activity; anticancer activity; enzyme inhibitors; inhibitors of MDR efflux pumps; bioguided isolation
The management of bacterial infections is a great challenge for therapeutics, particularly because of the increasing emergence of microorganisms with multiresistance to antibiotics, a phenomenon with important implications for morbidity and mortality. Even though the number of drugs currently used in clinical practice of infectious diseases is high, the development of resistance necessitates the discovery of new effective agents. Natural products have been an endless source of compounds with great structural diversity, showing various modes of action against resistant microorganisms. The enormous potential of plant-derived products for providing new and active chemical entities encourages scientists to continue searching for them. These structures will enrich natural product libraries to be used for the discovery of lead compounds and the development of drug candidates for successful therapies against resistant organisms.
This Special Issue intends to collect cutting-edge research and review works illustrating the potential of extracts and active principles obtained from plants, as well as derivatives therefrom against microorganisms, with special attention to those with resistant phenotypes, and it also aims to bring together pharmacognosists, chemists, pharmacologists, toxicologists, biologists, computer-aided drug design scientists, and clinicians working as a multidisciplinary team in the area of natural products.
Dr. Constantinos M. Athanassopoulos
Prof. Carlos L. Cespedes Acuña
Prof. María Cecilia Carpinella
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- plant extracts
- plant-derived compounds
- antibacterial activity
- antifungal activity
- resistant strains
- synthetic natural product derivatives
- multidrug resistance